Influenza Vaccination Among Patients with Noncommunicable Diseases: A Survey About Awareness, Usage, and Unmet Needs in the Czech Republic
People with noncommunicable diseases (NCDs) are at a higher risk of contracting vaccine-preventable diseases, such as influenza, with a higher likelihood of severity and complications.
Inflammageing mediated by cytotoxic lymphocytes is associated with diabetes duration
Type 2 diabetes is associated with increased tumor necrosis factor-α by CD8 T cells. Increased granzyme B production by natural killer cells and γδ T cells is observed in type 2 diabetes.
World Diabetes Day 2023: Why Influenza and Diabetes are important to consider jointly?
With the support of Sanofi, the Influenza Diabetes Community conducted a communications campaign to raise awareness of the impact of influenza on diabetes patients.
Influenza: Diabetes as a risk factor for severe related-outcomes and the effectiveness of vaccination in diabetic population. A meta-analysis of observational studies
In order to better define the need for influenza vaccination in people with diabetes (DM), we collected all available evidence on the effect of DM as a risk factor for complications of both seasonal and pandemic influenza.
Association of COVID-19 Infection With Incident Diabetes
SARS-CoV-2 infection may lead to acute and chronic sequelae. Emerging evidence suggests a higher risk of diabetes after infection, but population-based evidence is still sparse.
Influenza vaccination in patients affected by diabetes
The effects of vaccination appear to be more effective when using higher-dose and quadrivalent vaccines, although subgroup-specific separate analyses in patients with diabetes are lacking.
News
Partner Organisations
The biggest diabetes research stories of 2022
2022 has been a big year for diabetes research, filled with historic moments and world-firsts. Here we take a look back at some of the incredible progress Diabetes UK-funded scientists and diabetes researchers across the globe have been behind this year.
